Related Experiment Video
Updated: May 13, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Vertebral artery dissection associated with sildenafil abuse
Rick Dersch1, Constantin Anastasopoulos, Claudia Hader
1Department of Neurology, University Clinic Freiburg, Germany. Rick.Dersch@uniklinik-freiburg.de
Daily sildenafil use for sexual enhancement may increase the risk of arterial dissection, including vertebral artery dissection leading to cerebellar infarction. This case study suggests a potential link between chronic sildenafil use and arterial dissection.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Vertebral artery dissection can lead to ischemic stroke, particularly cerebellar infarction.
- Sildenafil is a phosphodiesterase type 5 inhibitor commonly used for erectile dysfunction and sexual enhancement.
- Previous reports have suggested a possible association between sildenafil and aortic dissection.
Observation:
- A 49-year-old male presented with cerebellar infarction secondary to vertebral artery dissection.
- The patient reported consistent daily use of sildenafil for at least two years for sexual enhancement.
- No recent sexual activity or preceding trauma was reported prior to symptom onset.
Findings:
- This case highlights a potential association between chronic, daily sildenafil use and arterial dissection.
- The patient's presentation suggests that sildenafil, even without recent sexual activity or trauma, may be implicated in arterial dissection events.
- The findings warrant further investigation into the potential risk factors associated with long-term sildenafil consumption.
Implications:
- Chronic sildenafil intake may represent an underrecognized risk factor for arterial dissection.
- Clinicians should consider medication history, including long-term sildenafil use, in patients presenting with arterial dissection.
- Further research is needed to elucidate the mechanisms and confirm the causal relationship between chronic sildenafil use and arterial dissection risk.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Aneurysm I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease III: Clinical Manifestations